Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
+$107M |
| 2 |
Alibaba
BABA
|
+$60.3M |
| 3 |
TSMC
TSM
|
+$46.7M |
| 4 |
Henry Schein
HSIC
|
+$30.2M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$24.8M |
Top Sells
| 1 |
Philip Morris
PM
|
+$91.6M |
| 2 |
Kellanova
K
|
+$57.6M |
| 3 |
Hain Celestial
HAIN
|
+$51.6M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$46M |
| 5 |
Microsoft
MSFT
|
+$44.5M |
Sector Composition
| 1 | Technology | 26.5% |
| 2 | Healthcare | 15.42% |
| 3 | Communication Services | 11.5% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
NNN REIT
NNN
$8.12B
| $8.48M | 0.07% |
164,037
+8,845
| +6% | +$457K |
|
277
Citizens Financial Group
CFG
$22.3B
| $8.48M | 0.07% |
424,646
-397,575
| -48% | -$7.94M |
|
278
Caterpillar
CAT
$198B
| $8.47M | 0.07% |
111,656
-5,042
| -4% | -$382K |
|
279
SM Energy
SM
$3.07B
| $8.36M | 0.07% |
309,618
-34,876
| -10% | -$942K |
|
280
US Bancorp
USB
$75.7B
| $8.3M | 0.07% |
205,796
-16,168
| -7% | -$652K |
|
|
ALXN
281
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.05M | 0.07% |
68,896
-4,635
| -6% | -$541K |
|
282
Thermo Fisher Scientific
TMO
$184B
| $7.88M | 0.07% |
53,314
-1,880
| -3% | -$278K |
|
283
Sabra Healthcare REIT
SBRA
$4.6B
| $7.74M | 0.06% |
375,194
+54,677
| +17% | +$1.13M |
|
284
Texas Instruments
TXN
$169B
| $7.64M | 0.06% |
122,023
-5,293
| -4% | -$332K |
|
285
Eli Lilly
LLY
$662B
| $7.54M | 0.06% |
95,789
+55,304
| +137% | +$4.35M |
|
286
Chubb
CB
$111B
| $7.49M | 0.06% |
57,286
-3,421
| -6% | -$447K |
|
287
Goldman Sachs
GS
$225B
| $7.42M | 0.06% |
49,892
-2,526
| -5% | -$375K |
|
288
American International
AIG
$43.6B
| $7.31M | 0.06% |
138,297
-137,933
| -50% | -$7.29M |
|
289
Biogen
BIIB
$20.7B
| $7.25M | 0.06% |
29,985
-2,061
| -6% | -$498K |
|
290
Pentair
PNR
$18.1B
| $7.24M | 0.06% |
185,008
-132,139
| -42% | -$5.17M |
|
291
New Oriental
EDU
$8.19B
| $7.16M | 0.06% |
170,964
-724,924
| -81% | -$30.4M |
|
|
HES
292
DELISTED
Hess
HES
| $7.1M | 0.06% |
118,167
+82,099
| +228% | +$4.93M |
|
293
NextEra Energy, Inc.
NEE
$144B
| $7.06M | 0.06% |
216,652
-16,332
| -7% | -$532K |
|
294
Abbott
ABT
$230B
| $6.91M | 0.06% |
175,912
-20,277
| -10% | -$797K |
|
295
JD.com
JD
$46.6B
| $6.91M | 0.06% |
+325,474
| New | +$6.91M |
|
296
Ashland
ASH
$2.49B
| $6.9M | 0.06% |
122,912
+32,682
| +36% | +$1.84M |
|
|
TWX
297
DELISTED
Time Warner Inc
TWX
| $6.9M | 0.06% |
93,850
-12,597
| -12% | -$926K |
|
298
Marsh & McLennan
MMC
$100B
| $6.9M | 0.06% |
100,782
| – | – |
|
299
Crown Castle
CCI
$40.9B
| $6.78M | 0.06% |
66,810
+25,727
| +63% | +$2.61M |
|
300
Crown Holdings
CCK
$11B
| $6.66M | 0.06% |
131,324
-159,037
| -55% | -$8.06M |
|